Skip to main content
Top
Published in: Endocrine Pathology 4/2017

01-12-2017

Depletion of Beta Cell Intranuclear Rodlets in Human Type II Diabetes

Authors: Yi Yuan Zhou, Soufiane El Hallani, Fady Balaa, Waleed Mohammad, Douglas A. Gray, John Woulfe

Published in: Endocrine Pathology | Issue 4/2017

Login to get access

Abstract

Intranuclear rodlets (INRs) are rod-shaped intranuclear bodies of unknown function present in the nuclei of pancreatic beta cells. Previous studies have demonstrated a significant depletion of INRs from beta cells in mouse models of type II diabetes, suggesting that they may have pathological significance. The objective of the present study was to determine whether beta cell INRs show quantitative alterations in human type II diabetes. In sections of non-neoplastic pancreas from 23 diabetic patients and 23 controls who had undergone complete or partial pancreatectomy, we detected a significant reduction in the proportion of INRs in insulin-immunoreactive beta cells. In addition, we showed that beta cell INRs are immunoreactive for the RNA-binding protein HuR. The results of this study confirm and extend our previous study and implicate this enigmatic nuclear structure in the cellular pathophysiological mechanisms underlying the development of type II diabetes in humans.
Literature
1.
go back to reference Wajchenberg BL Beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev 28: 187–218, 2007.CrossRefPubMed Wajchenberg BL Beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev 28: 187–218, 2007.CrossRefPubMed
3.
go back to reference Hoshino T Occurrence of intranuclear protein inclusion bodies in the beta cells of the Langerhans’ islets in chicks. Igaku to seibutsugaku. Medicine and Biology 78: 193–196, 1969.PubMed Hoshino T Occurrence of intranuclear protein inclusion bodies in the beta cells of the Langerhans’ islets in chicks. Igaku to seibutsugaku. Medicine and Biology 78: 193–196, 1969.PubMed
4.
go back to reference Prichett W, Milman P, Gagnon J, Munoz DG, Woulfe J Intranuclear rodlets in human pancreatic islet cells. Pancreas 35: 207–211, 2007.CrossRefPubMed Prichett W, Milman P, Gagnon J, Munoz DG, Woulfe J Intranuclear rodlets in human pancreatic islet cells. Pancreas 35: 207–211, 2007.CrossRefPubMed
5.
go back to reference Woulfe J, Munoz D Tubulin immunoreactive neuronal intranuclear inclusions in the human brain. Neuropathol Appl Neurobiol 26: 161–171, 2000.CrossRefPubMed Woulfe J, Munoz D Tubulin immunoreactive neuronal intranuclear inclusions in the human brain. Neuropathol Appl Neurobiol 26: 161–171, 2000.CrossRefPubMed
6.
go back to reference Woulfe JM, Hammond R, Richardson B et al. Reduction of neuronal intranuclear rodlets immunoreactive for tubulin and glucocorticoid receptor in Alzheimer’s disease. Brain Pathol 12: 300–307, 2002.CrossRefPubMed Woulfe JM, Hammond R, Richardson B et al. Reduction of neuronal intranuclear rodlets immunoreactive for tubulin and glucocorticoid receptor in Alzheimer’s disease. Brain Pathol 12: 300–307, 2002.CrossRefPubMed
7.
go back to reference Milman P, Fu A, Screaton RA, Woulfe JM Depletion of intranuclear rodlets in mouse models of diabetes. Endocr Pathol 21: 230–235, 2010.CrossRefPubMed Milman P, Fu A, Screaton RA, Woulfe JM Depletion of intranuclear rodlets in mouse models of diabetes. Endocr Pathol 21: 230–235, 2010.CrossRefPubMed
9.
go back to reference Avrahami D, Klochendler A, Dor Y, Glaser B Beta cell heterogeneity: an evolving concept. Diabetologia 60: 1363–1369, 2017.CrossRefPubMed Avrahami D, Klochendler A, Dor Y, Glaser B Beta cell heterogeneity: an evolving concept. Diabetologia 60: 1363–1369, 2017.CrossRefPubMed
10.
go back to reference Arntfield ME, van der Kooy D Beta-cell evolution: how the pancreas borrowed from the brain: the shared toolbox of genes expressed by neural and pancreatic endocrine cells may reflect their evolutionary relationship. BioEssays 33: 582–587, 2011.CrossRefPubMed Arntfield ME, van der Kooy D Beta-cell evolution: how the pancreas borrowed from the brain: the shared toolbox of genes expressed by neural and pancreatic endocrine cells may reflect their evolutionary relationship. BioEssays 33: 582–587, 2011.CrossRefPubMed
11.
go back to reference Leung YM, Kwan EP, Ng B, Kang Y, Gaisano HY SNAREing voltage-gated K+ and ATP-sensitive K+ channels: tuning beta-cell excitability with syntaxin-1A and other exocytotic proteins. Endocr Rev 28: 653–663, 2007.CrossRefPubMed Leung YM, Kwan EP, Ng B, Kang Y, Gaisano HY SNAREing voltage-gated K+ and ATP-sensitive K+ channels: tuning beta-cell excitability with syntaxin-1A and other exocytotic proteins. Endocr Rev 28: 653–663, 2007.CrossRefPubMed
12.
go back to reference Henquin JC, Meissner HP The ionic, electrical, and secretory effects of endogenous cyclic adenosine monophosphate in mouse pancreatic B cells: studies with forskolin. Endocrinol 115: 1125–1134, 1984.CrossRef Henquin JC, Meissner HP The ionic, electrical, and secretory effects of endogenous cyclic adenosine monophosphate in mouse pancreatic B cells: studies with forskolin. Endocrinol 115: 1125–1134, 1984.CrossRef
13.
go back to reference van Arensbergen J, Garcia-Hurtado J, Moran I et al. Derepression of Polycomb targets during pancreatic organogenesis allows insulin-producing beta-cells to adopt a neural gene activity program. Genome Res 20: 722–732, 2010.CrossRefPubMedPubMedCentral van Arensbergen J, Garcia-Hurtado J, Moran I et al. Derepression of Polycomb targets during pancreatic organogenesis allows insulin-producing beta-cells to adopt a neural gene activity program. Genome Res 20: 722–732, 2010.CrossRefPubMedPubMedCentral
14.
go back to reference Leszek J, Trypka E, Tarasov VV, Md Ashraf G, Aliev G Type 3 diabetes mellitus: a novel implication of Alzheimer disease. Curr Top Med Chem. 7(12):1331-1335, 2017.CrossRef Leszek J, Trypka E, Tarasov VV, Md Ashraf G, Aliev G Type 3 diabetes mellitus: a novel implication of Alzheimer disease. Curr Top Med Chem. 7(12):1331-1335, 2017.CrossRef
15.
go back to reference Juan-Mateu J, Rech TH, Villate O et al. Neuron-enriched RNA-binding proteins regulate pancreatic beta cell function and survival. J Biol Chem 292: 3466–3480, 2017.CrossRefPubMed Juan-Mateu J, Rech TH, Villate O et al. Neuron-enriched RNA-binding proteins regulate pancreatic beta cell function and survival. J Biol Chem 292: 3466–3480, 2017.CrossRefPubMed
16.
go back to reference Skliris A, Papadaki O, Kafasla P et al. Neuroprotection requires the functions of the RNA-binding protein HuR. Cell Death Differ 22: 703–718, 2015.CrossRefPubMed Skliris A, Papadaki O, Kafasla P et al. Neuroprotection requires the functions of the RNA-binding protein HuR. Cell Death Differ 22: 703–718, 2015.CrossRefPubMed
Metadata
Title
Depletion of Beta Cell Intranuclear Rodlets in Human Type II Diabetes
Authors
Yi Yuan Zhou
Soufiane El Hallani
Fady Balaa
Waleed Mohammad
Douglas A. Gray
John Woulfe
Publication date
01-12-2017
Publisher
Springer US
Published in
Endocrine Pathology / Issue 4/2017
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-017-9499-y

Other articles of this Issue 4/2017

Endocrine Pathology 4/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.